Home › Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Pag-aaral pangklinika para sa Chronic Inflammatory Demyelinating Polyradiculoneuropathy na nagre-recruit sa U.S.
17 pag-aaral para sa Chronic Inflammatory Demyelinating Polyradiculoneuropathy ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.
Mga lungsod na may pinakamaraming pag-aaral
- New York City, NY7 pag-aaral
- Houston, TX6 pag-aaral
- Miami, FL5 pag-aaral
- St. Louis, MO5 pag-aaral
- Indio, CA5 pag-aaral
- Washington, DC5 pag-aaral
- Philadelphia, PA5 pag-aaral
- Tampa, FL4 pag-aaral
- New Haven, CT4 pag-aaral
- Kansas City, KS4 pag-aaral
- San Francisco, CA4 pag-aaral
- Orlando, FL4 pag-aaral
- Birmingham, AL4 pag-aaral
- Melbourne, FL3 pag-aaral
- Raleigh, NC3 pag-aaral
- Milwaukee, WI3 pag-aaral
- Scottsdale, AZ3 pag-aaral
- Cleveland, OH3 pag-aaral
- Portland, OR3 pag-aaral
- Cincinnati, OH3 pag-aaral
- Seattle, WA3 pag-aaral
- Boston, MA3 pag-aaral
- Tucson, AZ3 pag-aaral
Ayos sa estado
- Alabama4 pag-aaral
- Arizona6 pag-aaral
- California11 pag-aaral
- Colorado4 pag-aaral
- Connecticut6 pag-aaral
- District of Columbia5 pag-aaral
- Florida10 pag-aaral
- Illinois4 pag-aaral
- Kansas4 pag-aaral
- Louisiana3 pag-aaral
- Massachusetts4 pag-aaral
- Michigan5 pag-aaral
- Missouri3 pag-aaral
- New York7 pag-aaral
- North Carolina7 pag-aaral
- Ohio6 pag-aaral
- Oregon3 pag-aaral
- Pennsylvania6 pag-aaral
- Tennessee4 pag-aaral
- Texas8 pag-aaral
- Washington3 pag-aaral
- Wisconsin3 pag-aaral
Mga pag-aaral na kamakailan lamang in-update
Opisyal na teksto ng pag-aaral (English)
Imeroprubart in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 13, 2026 · NCT07032662A Study to Evaluate the Pharmacokinetics and Safety of XEMBIFY Versus Gamunex-C in Participants With Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 10, 2026 · NCT07540221A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 9, 2026 · NCT07091630A Study Investigating Intravenous Human Normal Immune Globulin (IGIV) 10% KIg10 (QIVIGY) in Subjects With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 5, 2026 · NCT06752356Real-World Efgartigimod Effectiveness in CIDP: A Prospective Study
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 3, 2026 · NCT07264426A Study of TAK-411 in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 3, 2026 · NCT06798012A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 3, 2026 · NCT06920004A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)
Nagre-recruitPhase 3
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Okt 28, 2026 · NCT06858579A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 27, 2026 · NCT06680037Study of KITE-363 in Participants With Autoimmune Neurologic Diseases That Did Not Respond to Usual Treatment
Nagre-recruitPhase 1
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Okt 19, 2026 · NCT07304154A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 19, 2026 · NCT06290141Real-world Study of Treatment Outcomes in Chronic Inflammatory Demyelinating Polyneuropathy/Polyradiculoneuropathy (CIDP)
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 24, 2026 · NCT06968975A Worldwide Pregnancy Safety Study to Assess Maternal, Fetal, and Infant Outcomes Following Exposure to Efgartigimod During Pregnancy and/or Breastfeeding.
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Kababaihan · Na-update Peb 17, 2026 · NCT06299748A Study to Compare TAK-881 and HYQVIA in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Ene 20, 2026 · NCT06747351IVIG vs SCIG in CIDP
Nagre-recruitPhase 1
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Dis 11, 2025 · NCT05584631A Study of HyQvia in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) in Routine Clinical Care
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 21, 2025 · NCT06538064Biorepository and Registry for Plasma Exchange Patients
Nagre-recruitObservasyonal na pag-aaral
Edad 12 hanggang 99 · Lahat ng kasarian · Na-update May 20, 2025 · NCT05004493Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.